Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Neoplasms 5Pain 3Cachexia 3Breast Neoplasms 3Trigger Finger Disorder 2Lung Neoplasms 2Inflammation 2Ganglion Cysts 2De Quervain Disease 2Colorectal Neoplasms 2Weight Loss 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Prostatitis 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Mucositis 1Menorrhagia 1Median Neuropathy 1Mastocytosis, Systemic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Leiomyoma 1Kidney Neoplasms 1Hodgkin Disease 1Hemorrhage 1

Interventions

Low-Level Light Therapy 5Radiation 4Radiotherapy 3Propolis 3Morphine 3Methotrexate 3Leucovorin 3Cryotherapy 3Cisplatin 3glucarpidase 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2Fibroblast Growth Factor 7 2Drug Therapy 2Amifostine 2peppermint oil 1pegfilgrastim 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1maltodextrin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucositis × Ibuprofen × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡